Ads
related to: Treat Macular Degeneration
Search results
Cambridge Investment Research Advisors Inc. Sells 2,003 Shares of Regeneron Pharmaceuticals, Inc....
ETF DAILY NEWS· 2 days agoCambridge Investment Research Advisors Inc. lowered its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 19.8% during the fourth quarter, according to the company in ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoJeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion This acquisition reflects the significant clinical progress achieved with Restoret™, EyeBio’s novel late-phase
US Bancorp DE Has $4.34 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 2 days agoUS Bancorp DE grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% in the 4th quarter, according to the company in its most recent disclosure with ...